7,5\'-Dihydroxy-5,4\'-dimethoxy-3\'-prenylisoflavone 7-O-galactoside



Compound IDCDAMM01836
Common name7,5\'-Dihydroxy-5,4\'-dimethoxy-3\'-prenylisoflavone 7-O-galactoside
IUPAC name3-[3-hydroxy-4-methoxy-5-(3-methylbut-2-enyl)phenyl]-5-methoxy-7-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one
Molecular formulaC28H32O11

Experimental data

Retention time4.12
Adduct[M+H]+
Actual mz545.202
Theoretical mz545.201
Error0.59
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.6828

Identifiers and class information

Inchi keyDWLRNWOJJADWTC-YLBSRKPPNA-N
SmilesO=C1C(=COC2=CC(OC3OC(CO)C(O)C(O)C3O)=CC(OC)=C12)C=4C=C(O)C(OC)=C(C4)CC=C(C)C
SuperclassPhenylpropanoids and polyketides
ClassIsoflavonoids

Pharmacokinetic properties

Number of descriptor values(#stars)1
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)13
Number of reactive functional groups (#rtvFG)1
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)544.554
Computed dipole moment(dipole)6.306
Total solvent accessible surface area (SASA)851.011
Hydrophobic component of SASA (FOSA)450.485
Hydrophilic component of SASA (FISA)242.522
Pie component of the SASA (PISA)158.004
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1581.15
Number of hydrogen bond donors (donorHB)5
Number of hydrogen bond acceptors (accptHB)14
Free energy of solvation of dipole (dip^2/V)0.0251513
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0367856
Globularity descriptor (glob)0.771279
Predicted polarizability in cubic angstroms (QPpolrz)50.285
Predicted hexadecane/gas partition coefficient (QPlogPC16)17.049
Predicted octanol/gas partition coefficient (QPlogPoct)31.978
Predicted water/gas partition coefficient (QPlogPw)22.737
Predicted octanol/water partition coefficient (QPlogPo/w)1.431
Predicted aqueous solubility (QPlogS)-4.566
Conformation-independent predicted aqueous solubility (CIQPlogS)-5.519
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-5.986
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)49.667
Predicted brain/blood partition coefficient (QPlogBB)-2.938
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)19.273
Predicted skin permeability, log Kp (QPlogKp)-4.184
PM3 calculated ionization potential (IP(ev))8.76
PM3 calculated electron affinity (EA(eV))0.481
Number of likely metabolic reactions (#metab)10
Prediction of binding to human serum albumin (QPlogKhsa)-0.417
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)39.766
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)167.016
Number of nitrogen and oxygen atoms (#NandO)11
Number of violations of Lipinski’s rule of five (RuleOfFive)2
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P43166CA7Carbonic anhydrase VIIT37541SEA
P60568IL2Interleukin-2T61698SEA
P30837ALDH1B1Acetaldehyde dehydrogenaseT99641SEA
P14679TYRTyrosinaseT97035SEA
Q9GZQ4NMUR2Neuromedin-U receptor 2T04210SEA
P16152CBR1Carbonyl reductase [NADPH] 1T70518SEA
Q13332PTPRSReceptor-type tyrosine-protein phosphatase ST10147SEA
Q9NZ08ERAP1Endoplasmic reticulum aminopeptidase 1T72849SEA
P05231IL6Interleukin-6T32578SEA
P30837ALDH1B1Acetaldehyde dehydrogenaseT99641SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T61698DI0275Multiple sclerosis[ICD-11: 8A40]P60568IL2
T61698DI0361Renal cell carcinoma[ICD-11: 2C90]P60568IL2
T99641DI0396Substance abuse[ICD-11: 6C40]P30837ALDH1B1
T97035DI0007Acquired hypermelanosis[ICD-11: ED60]P14679TYR
T97035DI0008Acquired hypomelanotic disorder[ICD-11: ED63]P14679TYR
T70518DI0037Asthma[ICD-11: CA23]P16152CBR1
T10147DI0057Bone paget disease[ICD-11: FB85]Q13332PTPRS
T32578DI0028Anemia[ICD-11: 3A00-3A9Z]P05231IL6
T99641DI0396Substance abuse[ICD-11: 6C40]P30837ALDH1B1

Copyright © 2025